 |
World leading innovative drug discovery & developmentOur research and development teams utilize our cutting edge technology platform in the relentless pursuit of innovative solutions that address the extensive and complex challenges in oncology and diseases of the CNS. |
Astex has built a rich product portfolio with multiple drugs in preclinical and clinical development.
We also have a number of partnered products being developed under our collaboration and license agreements with major pharmaceutical companies including three approved drugs that are now on the market.
Astex News Updates
Astex wins Business Weekly Award for “Deal of the Year” for exclusive, worldwide research collaboration and licence agreement with Genentech
Drug firms’ secret data supercharge AI protein models
Astex Announces Exclusive Research Collaboration and License Agreement with Genentech for Breast Cancer Therapy Program
Astex is proud to announce that Dr David Rees, former Chief Scientific Officer of Astex and Chair of our Scientific Advisory Board, was appointed a Commander of the Order of the British Empire (CBE) in the King’s Birthday honours list for services to Chemistry and Innovation.
Follow us on LinkedIn
Sustaining Innovation
Sustaining Innovation Postdoctoral Training Program
Career Opportunities
We seek to attract and retain talented individuals who are passionate about improving patient outcomes.
© Astex Pharmaceuticals
All rights reserved
